NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma

Gliomas account for 75% of all primary malignant brain tumors in adults and are associated with high mortality. Mounting evidence has shown that NCAPG2 is differentially expressed in various cancers. However, the prognostic value and immune functions of NCAPG2 in low-grade glioma (LGG) remain unreso...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Wenjun, Yang, Shu, Chen, Xi, Guo, Jishu, Zhao, Heng, Yang, Ruihan, Nie, Zhi, Ding, Li, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309203/
https://www.ncbi.nlm.nih.gov/pubmed/35898895
http://dx.doi.org/10.3389/fonc.2022.918606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309203/
https://www.ncbi.nlm.nih.gov/pubmed/35898895
http://dx.doi.org/10.3389/fonc.2022.918606

Ejemplares similares